Stockholm - Free Realtime Quote SEK
CHOSA Oncology AB (CHOSA.ST)
As of 12:46 PM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Gerton Jonsson | Chief Financial Officer | -- | -- | 1971 |
| Ms. Ulla Hald Buhl | COO & Board Member | -- | -- | 1964 |
| Mr. Claus Frisenberg Pedersen | Chief Commercial Officer & Board Member | -- | -- | 1972 |
CHOSA Oncology AB
- Sector:?
- Healthcare
- Industry:? Biotechnology
Description
Chosa Oncology AB develops oncology drugs for the treatment of cancer. The company was formerly known as Chosa ApS. Chosa Oncology AB incorporated in 2022 and is based in Lund, Sweden.
Corporate Governance
CHOSA Oncology AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
LIDDS.ST LIDDS AB (publ)
0.1345
-15.94%
APTA.ST Aptahem AB (publ)
1.5300
-7.27%
ZICC.ST Ziccum AB (publ)
2.3000
-2.95%
NANECH.ST NanoEcho AB
0.2200
-3.51%
PCIB.OL PCI Biotech Holding ASA
1.5820
-3.30%
DIABIO.ST Diagonal Bio AB (publ)
0.0319
-4.20%
KAN.ST Kancera AB (publ)
1.5460
-5.50%
ULTI.OL Ultimovacs ASA
1.8940
+9.48%
ACTI.ST Active Biotech AB (publ)
0.1638
-1.80%
CRNA.OL Circio Holding ASA
0.9480
-0.22%